Acquisition and Divestitures (Tables)

9 Months Ended

Sep. 30, 2013

Clinical Instruments [Member]

Summary of Fair Value of Assets Acquired and Liabilities Assumed

The following table summarizes the fair value of the assets acquired and liabilities assumed at the date of the acquisition:

	Allocated Fair Value
	(in thousands)
Current assets	$	169
Intangible assets		322
Goodwill		614
Total assets acquired		1,105
Total liabilities assumed		—
	$	1,105

Acquired Intangible Assets and Related Estimated Useful Lives

Of the $0.3 million of acquired intangible assets, the following table reflects the allocation of the acquired intangible assets and related estimated useful lives:

	Allocated Fair Value		Weighted Average Useful Life
	(in thousands)
Non-compete agreement	$	95	5.0 years
Technology	$	147	6.0 years
Customer relationships		80	6.0 years
Total intangible assets	$	322

InaVein LLC [Member]

Summary of Fair Value of Assets Acquired and Liabilities Assumed

The following table summarizes the fair value of the assets acquired and liabilities assumed at the date of the acquisition:

	Allocated Fair Value
	(in thousands)
Current assets	$	670
Property and equipment, net		154
Intangible assets		1,143
Goodwill		668
Total assets acquired		2,635
Total liabilities assumed		(100	)
	$	2,535

Acquired Intangible Assets and Related Estimated Useful Lives

Of the $1.1 million of acquired intangible assets, the following table reflects the allocation of the acquired intangible assets and related estimated useful lives:

	Allocated Fair Value		Weighted Average Useful Life
	(in thousands)
Non-compete agreement	$	70	5.0 years
Tradename		163	8.0 years
Technology		354	6.0 years
Customer relationships		556	7.0 years
Total intangible assets	$	1,143